Limited cancer screening + FDG PET/CT for Blood Clot

Hôpital Saint Musse - CH Toulon, Toulon, France
Blood Clot+1 More ConditionsLimited cancer screening + FDG PET/CT - DiagnosticTest
All Sexes
What conditions do you have?

Study Summary

This trial found that VTE can be the earliest sign of cancer and that identifying occult cancers at the time of VTE diagnosis may lead to significant improvement of patients' care.

Eligible Conditions
  • Blood Clot

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: At 1 year of follow-up

At 1 month
Occult cancer diagnosed by screening strategies
Year 1
Additional tests
Cost effectiveness analysis
Decision aid to assist patients in the decision of cancer screening
Early vs Adanced-stage cancers
Occult cancer missed by screening strategies
Recurrent VTE
Year 5
Cancer-related mortality

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Limited cancer screening
1 of 2
Limited cancer screening + FDG PET/CT
1 of 2

Active Control

Experimental Treatment

1276 Total Participants · 2 Treatment Groups

Primary Treatment: Limited cancer screening + FDG PET/CT · No Placebo Group · N/A

Limited cancer screening + FDG PET/CT
Experimental Group · 1 Intervention: Limited cancer screening + FDG PET/CT · Intervention Types: DiagnosticTest
Limited cancer screening
ActiveComparator Group · 1 Intervention: Limited cancer screening · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at 1 year of follow-up

Who is running the clinical trial?

Ministry of Health, FranceOTHER_GOV
364 Previous Clinical Trials
362,196 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,268 Previous Clinical Trials
25,600,299 Total Patients Enrolled
Ottawa Hospital Research InstituteOTHER
544 Previous Clinical Trials
2,516,731 Total Patients Enrolled
University Hospital, BrestLead Sponsor
483 Previous Clinical Trials
223,189 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

In how many locales is this investigation functioning?

"Numerous locations across Canada are recruiting participants, including the University of Calgary in Calgary, McMaster University in Hamilton, and the University of Manitoba in Winnipeg. Additionally, there are several other sites where patients may be enrolled." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.